Iterum Therapeutics PLC (ITRM) — Financial Flexibility Index
Iterum Therapeutics PLC (ITRM) has a Financial Flexibility Index of -0.20x as of September 2025. Free cash flow of $-7.84 Million (operating CF $-7.85 Million minus capex $12.57K) represents 0% of total liabilities ($39.88 Million). Check Iterum Therapeutics PLC tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Iterum Therapeutics PLC Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Iterum Therapeutics PLC across 9 annual periods. For the full cash flow conversion analysis, see Iterum Therapeutics PLC (ITRM) cash flow conversion.
Annual Financial Flexibility Index for Iterum Therapeutics PLC (2016–2024)
Year-by-year free cash flow to debt coverage for Iterum Therapeutics PLC. Explore cash flow to debt ratio of Iterum Therapeutics PLC to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | $-26.77 Million | $-26.77 Million | $48.68 Million | ▲ +54.3% |
| 2023 | -1.20x | $-39.32 Million | $-39.33 Million | $32.66 Million | ▼ -153.9% |
| 2022 | -0.47x | $-18.41 Million | $-18.47 Million | $38.83 Million | ▼ -24.0% |
| 2021 | -0.38x | $-15.78 Million | $-15.84 Million | $41.27 Million | ▲ +41.5% |
| 2020 | -0.65x | $-54.52 Million | $-54.53 Million | $83.35 Million | ▲ +58.5% |
| 2019 | -1.58x | $-81.90 Million | $-81.92 Million | $51.99 Million | ▲ +45.4% |
| 2018 | -2.89x | $-75.80 Million | $-75.89 Million | $26.25 Million | ▲ +29.6% |
| 2017 | -4.10x | $-29.79 Million | $-30.60 Million | $7.26 Million | ▼ -66.2% |
| 2016 | -2.47x | $-10.49 Million | $-11.30 Million | $4.25 Million | — |